US-based pharmaceutical manufacturer and marketer Forest Laboratories (FRX) has received qualified infectious disease product (QIDP) designation for its ceftazidime/avibactam drug from the US Food and Drug Administration (FDA). Currently ...
Tags: drug, Forest Laboratories
Global health care company Fresenius Kabi USA has rolled out its Levofloxacin in 5% Dextrose injection in freeflex containers, designed for better infusion of solutions. Considering easy handling with improved safety and environmental ...
Tags: Fresenius Kabi, Freeflex Container
Fresenius Kabi USA has announced the availability of Levofloxacin in 5% dextrose injection in freeflex containers. Freeflex is a PVC-free, plasticizer-free, non-DEHP container, which is designed for easy handling and infusing the ...
Tags: Fresenius Kabi, Freeflex Container
UK-based Randox Food Diagnostics is set to unveil a generic Tetracyclines ELISA screening kit based on Biochip Array Technology for veterinary residue testing. The company will launch the ELISA kit by the end of this month to complement ...
Tags: Randox Food, Screening Kit
Changing consumer demand in terms of fashion and quality has sustained the development of the mature and saturated workwear and uniforms market in Western Europe. As the need for traditional blue workwear decreases, existing suppliers are ...
Tags: Workwear Market, Apparel
Clinical-stage pharmaceutical company Cempra has received a notification of patent allowance from the US Patent and Trademark Office (USPTO) for taksta loading dose formulation. With the possibility for extension, the patent entitled ...
Orchid Pharma and Allecra Therapeutics have entered into a strategic partnership for the development of novel antibiotics against multi-drug resistant bacterial infections. Orchid has assigned Intellectual Property (IP) related to an ...
Quidel and Life Technologies have received 510(k) approval from US FDA to market the Quidel Molecular Direct C. difficile Assay with Life Technologies' QuantStudio Dx and 7500 Fast Dx Applied Biosystems Real-Time PCR Instruments. The ...
Tags: Quidel, Life Technologies, FDA Approval
The shortage of doxycycline recently announced by the Food and Drug Administration could leave many people searching for alternatives because the antibiotic is used to treat a wide range of conditions that afflict millions, including acne, ...
If you haven't come down with the flu yet, there's still a good chance that you will. The Centers for Disease Control and Prevention says flu season is likely to last several more weeks, leading to fever, aches, headaches, and general ...
Lorus Therapeutics has received first Japanese patent for its small molecule anticancer drug LOR-253 that will provide Lorus with exclusive rights to LOR-253 in Japan until 2023. The patent will provide protection for LOR-253 composition ...